Analysts at Jefferies Financial Group initiated coverage on shares of ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $35.00 price target on the stock. Jefferies Financial Group’s target price suggests a potential upside of 76.06% […]
Related Keywords
Arrivent Biopharma , Analysts At Jefferies Financial Group , Orbimed Advisors Llc , Securities Exchange Commission , Goldman Sachs Group , Jefferies Financial Group , Arrivent Biopharma Company Profile , Arrivent Biopharma Inc , Citigroup , Get Free Report , Financial Group , Hillhouse Investment Managemen , Exchange Commission , Director Orbimed Advisors Llc , Vent Biopharma , Arrivent Biopharma Daily , Nasdaq Avbp , Avbp , Medical , Initiated Coverage , Jefferies Financial Group Inc ,
comparemela.com © 2020. All Rights Reserved.